Information:
Fel:
ID
43825
Beskrivning
Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00275106
Länk
https://clinicaltrials.gov/show/NCT00275106
Nyckelord
Versioner (3)
- 2016-10-12 2016-10-12 -
- 2016-10-12 2016-10-12 -
- 2021-09-20 2021-09-20 -
Uppladdad den
20 september 2021
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Lymphoma NCT00275106
Eligibility Lymphoma NCT00275106
- StudyEvent: Eligibility
Similar models
Eligibility Lymphoma NCT00275106
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
adult lymphoblastic lymphoma
Item
histologically or cytologically confirmed lymphoblastic lymphoma (lbl)
boolean
C0278721 (UMLS CUI [1])
TNM clinical staging
Item
stage i-iv disease
boolean
C3258246 (UMLS CUI [1])
Lymphoblastic T-cell lymphoma | Precursor B-cell lymphoblastic lymphoma | adult lymphoblastic lymphoma Immunophenotype Unknown
Item
t-cell lbl, precursor b-cell lbl, or lbl with an unknown immunophenotype
boolean
C2853920 (UMLS CUI [1])
C0855146 (UMLS CUI [2])
C0278721 (UMLS CUI [3,1])
C0079611 (UMLS CUI [3,2])
C0439673 (UMLS CUI [3,3])
C0855146 (UMLS CUI [2])
C0278721 (UMLS CUI [3,1])
C0079611 (UMLS CUI [3,2])
C0439673 (UMLS CUI [3,3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Pregnancy test negative
Item
negative pregnancy test
boolean
C0427780 (UMLS CUI [1])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception during and for 3 months after completion of study treatment
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,2])
HIV Infection | Acquired Immunodeficiency Syndrome
Item
no known hiv or aids infection
boolean
C0019693 (UMLS CUI [1])
C0001175 (UMLS CUI [2])
C0001175 (UMLS CUI [2])
Immunologic Deficiency Syndrome Severe
Item
no severe immunodeficiency
boolean
C0021051 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Malignant Neoplasms
Item
no other prior malignancy
boolean
C0006826 (UMLS CUI [1])
Disease Excludes Chemotherapy
Item
no prior disease that would preclude treatment with chemotherapy
boolean
C0012634 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
C0332196 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
Prior Therapy
Item
prior concurrent therapy:
boolean
C1514463 (UMLS CUI [1])
systemic steroids
Item
more than 2 months since prior systemic corticosteroids for a duration of > 8 days
boolean
C2825233 (UMLS CUI [1])
Prior Chemotherapy
Item
no prior chemotherapy
boolean
C1514457 (UMLS CUI [1])
prior radiation therapy
Item
no prior radiotherapy
boolean
C0279134 (UMLS CUI [1])
Organ Transplantation
Item
no prior organ transplant
boolean
C0029216 (UMLS CUI [1])
Trimethoprim-Sulfamethoxazole Combination | Methotrexate
Item
no trimethoprim-sulfamethoxazole 6 days before or during methotrexate therapy
boolean
C0041044 (UMLS CUI [1])
C0025677 (UMLS CUI [2])
C0025677 (UMLS CUI [2])
Study Subject Participation Status
Item
no concurrent participation in another clinical trial
boolean
C2348568 (UMLS CUI [1])